* Viveve Medical Inc VIVE.OQ VIVE.O is expected to show
a rise
in quarterly revenue when it reports results on May 12.
* The Englewood Colorado-based company is expected to
report a
21.7% increase in revenue to $1.765 million from $1.45 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Viveve Medical Inc
is for
a loss of 57 cents per share. For the same quarter last year,
the company reported a loss of 80 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Viveve
Medical
Inc is $5.38, above its last closing price of $0.78.
This summary was machine generated May 10 at 23:41 GMT. All
figures in US dollars unless otherwise stated